secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001213900-25-106454
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne Medical receives Nasdaq extension to May 4, 2026 to regain $1.00 bid price compliance
--------------------------------------------------------------------------------

- Nasdaq granted a 180-day extension until May 4, 2026 for minimum bid price compliance.
- Company previously disclosed non-compliance on May 9, 2025; initial cure period expired Nov 3, 2025.
- If not compliant by May 4, 2026, Nasdaq may delist; company can appeal to a hearing panel.
- Listing remains fully effective during extension; no immediate impact on common stock trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390025106454/0001213900-25-106454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390025106454/ea0263939-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-106454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer